KMDA
Kamada Ltd. · Healthcare · Drug Manufacturers - Specialty & Generic
Señales de momentum (gestores comparables):
amplitud de titulares -3.8% ·
flujo de acciones -6.0% ·
nuevas posiciones netas -4.0%
· fórmula
Distribución amplia: acciones en descenso y menos titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 27 | +5 | 2.57M | $19.13M | +6 | −1 |
| Q1 2026 | 22 | -3 | 2.50M | $509.41M | +1 | −4 |
| Q4 2025 | 25 | -1 | 2.61M | $442.17M | n/a | −1 |
| Q3 2025 | 12 | 0 | 1.99M | $13.83M | n/a | n/a |
| Q2 2025 | 9 | +2 | 1.71M | $13.25M | +2 | n/a |
| Q1 2025 | 6 | +2 | 1.56M | $10.32M | +2 | n/a |
| Q4 2024 | 4 | 0 | 1.20M | $7.32M | n/a | n/a |
| Q3 2024 | 4 | 0 | 1.28M | $6.90M | n/a | n/a |
| Q2 2024 | 4 | n/a | 993.01K | $4.93M | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wells Fargo & Company/Mn | 603.62K | n/a | $427.99M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | Renaissance Technologies ✦ | 839.30K | -3.8% | $5.93M | 0.0% | ▼ Trim | 7 | SEC ↗ |
| 3 | Marshall Wace ✦ | 196.95K | +25.9% | $1.39M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Goldman Sachs Group ✦ | 167.52K | +43.3% | $1.18M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 5 | Millennium Management ✦ | 157.61K | -31.1% | $1.11M | 0.0% | ▼ Trim | 7 | SEC ↗ |
| 6 | Two Sigma Investments ✦ | 140.68K | +28.4% | $993,215 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Arrowstreet Capital ✦ | 116.63K | +236.4% | $827,090 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 68.40K | +153.8% | $482,889 | 0.0% | ▲ Add | 7 | SEC ↗ ×2 |
| 9 | JPMorgan Chase ✦ | 57.28K | -30.1% | $404,383 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | UBS Group AG | 55.33K | n/a | $390,623 | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 11 | Bank Of America Corp /De/ | 39.66K | n/a | $280,028 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 12 | BlackRock ✦ (pasivo) | 38.45K | +238.4% | $271,443 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Man Group plc | 34.29K | n/a | $242,116 | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Geode Capital Management ✦ (pasivo) | 29.41K | 0.0% | $207,627 | 0.0% | Held | 7 | SEC ↗ |
| 15 | Jane Street Group, Llc | 21.16K | n/a | $149,389 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 16 | Morgan Stanley ✦ | 12.41K | -81.8% | $87,622 | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 17 | Envestnet Asset Management Inc | 10.13K | n/a | $71,532 | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Focus Partners Wealth | 10.00K | n/a | $70,600 | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Barclays Plc | 4.79K | n/a | $33,803 | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Mirae Asset Global Investments Co.… | 2.80K | n/a | $19,789 | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Citigroup Inc | 1.61K | n/a | $11,424 | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Royal Bank Of Canada | 1.27K | n/a | $9,000 | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Bnp Paribas Financial Markets | 1.24K | n/a | $8,783 | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Daiwa Securities Group Inc. | 192 | n/a | $1,000 | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Osaic Holdings, Inc. | 135 | n/a | $953 | 0.0% | n/c | 1 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| ARK Investment Management | $1.78M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 41 tenedores, 5.10M acciones, $528.34M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Director · 22.83K acc. · $186,725
Director · 175 acc. · $1,446
Director · 162.76K acc. · $1.34M
Director · 14.24K acc. · $117,891
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología